ABT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ABT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Abbott Laboratories's Other Current Payables for the quarter that ended in Sep. 2024 was $956 Mil.
Abbott Laboratories's quarterly Other Current Payables stayed the same from Mar. 2024 ($959 Mil) to Jun. 2024 ($959 Mil) but then declined from Jun. 2024 ($959 Mil) to Sep. 2024 ($956 Mil).
Abbott Laboratories's annual Other Current Payables increased from Dec. 2021 ($1,195 Mil) to Dec. 2022 ($1,525 Mil) and increased from Dec. 2022 ($1,525 Mil) to Dec. 2023 ($1,605 Mil).
The historical data trend for Abbott Laboratories's Other Current Payables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Other Current Payables | Get a 7-Day Free Trial | 847.00 | 1,114.00 | 1,195.00 | 1,525.00 | 1,605.00 |
Abbott Laboratories Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Other Current Payables | Get a 7-Day Free Trial | 886.00 | 1,605.00 | 959.00 | 959.00 | 956.00 |
Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.
Thank you for viewing the detailed overview of Abbott Laboratories's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.
Hubert L Allen | officer: Executive Vice President | 100 ABBOTT PARK ROAD, AP6C-1N, ABBOTT PARK IL 60064-6092 |
Robert B Ford | officer: Senior Vice President | 100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064-6092 |
Mccoy John A. Jr. | officer: VICE PRESIDENT | C/O ABBOTT LABORATORIES, 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064 |
Robert E Funck | officer: Vice President, Controller | 100 ABBOTT PARK ROAD, D-378, AP6D-2, ABBOTT PARK IL 60064-6092 |
Lisa D Earnhardt | officer: Executive Vice President | 1555 ADAMS DRIVE, C/O INTERSECT ENT, INC., MENLO PARK CA 94025 |
Salvadori Daniel Gesua Sive | officer: Senior Vice President | 100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064-6092 |
Mary K Moreland | officer: Executive Vice President | 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064 |
Louis H. Morrone | officer: EXECUTIVE VICE PRESIDENT | 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064 |
Andrea F Wainer | officer: Executive Vice President | 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064 |
Daniel J Starks | director | ONE ST JUDE MEDICAL DRIVE, ST PAUL MN 55117 |
Michael F Roman | director | 3M COMPANY OFFICE OF GENERAL COUNSEL, 3M CENTER, ST. PAUL MN 55144-1000 |
Patricia Paola Gonzalez | director | 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064 |
Philip P Boudreau | officer: Vice President | 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064 |
Michael O'grady | director | 50 S LASALLE STREET, CHICAGO IL 60603 |
Gregory A Ahlberg | officer: Senior Vice President | 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064 |
From GuruFocus
By PRNewswire • 11-25-2024
By PRNewswire • 10-24-2024
By GuruFocus News • 11-13-2024
By GuruFocus News • 10-17-2024
By GuruFocus News • 11-01-2024
By PRNewswire • 09-26-2024
By PRNewswire • 09-19-2024
By GuruFocus News • 10-16-2024
By GuruFocus News • 11-16-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.